The prefrontal cortex emerges as a possible inhibitory interactor of hypothalamic orexinergic activity, and prefrontal disruption could mediate orexinergic tone deregulation, explaining higher orexin A concentrations in bvFTD patients. The gene discussed is HCRT; the disease is behavioral variant of frontotemporal dementia.